Trial site
Medical Care and Research S.A. de C.V.
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- Obesity3 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Metastatic breast cancer2 trials
- Systemic sclerosis (scleroderma)2 trials
- Triple-negative breast cancer2 trials
- Heart failure1 trial
- Migraine1 trial
- Schizophrenia1 trial
- Type 1 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 312 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Novo Nordisk A/S6 trials
- Gilead Sciences2 trials
- argenx1 trial
- Carmot Therapeutics, Inc.1 trial
- Gedeon Richter Plc.1 trial
- and 5 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
Active, not recruiting
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Heart failure1 recruiting
- Type 1 diabetes1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Withdrawn
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Terminated
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Site data: ClinicalTrials.govUpdated 17 Nov 2026